Genetics of colorectal cancer
Colorectal cancer (CRC) is the second leading cause of cancer-related mortality in the United States. As such, it assumes a significant role in both health policy decision-making and scientific research. CRC has been a model for investigating the molecular genetics of cancer development and progress...
Saved in:
Published in | Medscape general medicine Vol. 6; no. 3; p. 13 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United States
Medscape
13.08.2004
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Colorectal cancer (CRC) is the second leading cause of cancer-related mortality in the United States. As such, it assumes a significant role in both health policy decision-making and scientific research. CRC has been a model for investigating the molecular genetics of cancer development and progression; this is in part due to the easily detectable, sequential transition of cells from normal colonic epithelium to adenoma and then to adenocarcinoma. In addition, familial syndromes that predispose to CRC, such as familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC), have significantly contributed to our understanding of the genetic mechanisms underlying CRC formation. It is now well recognized that hereditary CRC syndromes are due to germline mutations of genes that function as tumor suppressors or, less frequently, oncogenes. Accumulation of subsequent mutations in other genes with related functions results in the stepwise progression to carcinoma. It is important to note that somatic changes in similar genes are involved in the formation of sporadic CRC. The identification of these important CRC-related genes may help facilitate the early diagnosis, prevention, and treatment of CRC. This article reviews the various familial CRC syndromes along with their genetic etiology, as well as discusses the principle of genetic testing for these conditions. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 V.W.Y. is the recipient of a Georgian Cancer Coalition Distinguished Cancer Clinician Scientist Award Disclosure: Vincent Yang, MD, PhD, has no significant financial interests or relationships to disclose. Disclosure: Irfan M. Hisamuddin, MD, has no significant financial interests or relationships to disclose. |
ISSN: | 1531-0132 |